Brandi Binkley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Brandi Binkley has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Peng Li
Lehigh University
3 shared publications Amanda Overby
C. Eugene Bennett Department of Chemistry
1 shared publicationBethany J. Fike
C. Eugene Bennett Department of Chemistry
1 shared publication- Bethany J. Fike
C. Eugene Bennett Department of Chemistry, West Virginia University, Morgantown, WV 26506, USA
1 shared publication Herbi Yuliantoro
C. Eugene Bennett Department of Chemistry
1 shared publication- Kathrine Curtin
West Virginia University
1 shared publication
Latest Publications
- Top Cited PapersOpen Access
- 25 March 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (13) , 6847-6870
Acoustofluidics: Technology Advances and Applications from 2022 to 2024
- 25 March 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (13) , 6847-6870
Top Cited PapersOpen AccessAcoustofluidics: Technology Advances and Applications from 2022 to 2024
- Open Access
- 25 March 2025
- Published by MDPI AG in Biosensors
- Vol. 15 (4) , 211
A Facile Surface Modification Strategy for Antibody Immobilization on 3D-Printed Surfaces
3D-printed microdevices have become increasingly important to the advancement of point-of-care (POC) immunoassays. Despite its great potential, using 3D-printed surfaces on the solid support for immunorecognition has been limited due to the non-ideal adsorption properties for many photocurable resins. In this work, we report a simple surface modification protocol that works for diverse commercial photocurable resins, improving ELISAs performed directly on 3D-printed devices. This surface modification strategy involves surface activation via air plasma followed by the one-step incubation of GLYMO-labeled streptavidin. We successfully immobilized biotinylated anti-activin A antibodies on the 3D-printed surfaces and performed the complete ELISA protocol on the 3D-printed surfaces. We demonstrated that this protocol achieved an improved performance over passive adsorption for ELISAs. The present method is also compatible with diverse commercial resins and works with both microwells and microchannels. Finally, this method demonstrated a comparable limit of detection to the ELISA performed using commercial microwells. We believe the simplicity and broad compatibility of the present surface modification strategy will facilitate the development of 3D-printed POC ELISA devices.
- 25 March 2025
- Published by MDPI AG in Biosensors
- Vol. 15 (4) , 211
Open AccessA Facile Surface Modification Strategy for Antibody Immobilization on 3D-Printed Surfaces
3D-printed microdevices have become increasingly important to the advancement of point-of-care (POC) immunoassays. Despite its great potential, using 3D-printed surfaces on the solid support for immunorecognition has been limited due to the non-ideal adsorption properties for many photocurable resins. In this work, we report a simple surface modification protocol that works for diverse commercial photocurable resins, improving ELISAs performed directly on 3D-printed devices. This surface modification strategy involves surface activation via air plasma followed by the one-step incubation of GLYMO-labeled streptavidin. We successfully immobilized biotinylated anti-activin A antibodies on the 3D-printed surfaces and performed the complete ELISA protocol on the 3D-printed surfaces. We demonstrated that this protocol achieved an improved performance over passive adsorption for ELISAs. The present method is also compatible with diverse commercial resins and works with both microwells and microchannels. Finally, this method demonstrated a comparable limit of detection to the ELISA performed using commercial microwells. We believe the simplicity and broad compatibility of the present surface modification strategy will facilitate the development of 3D-printed POC ELISA devices.
- Open Access
- 23 August 2022
- Published by MDPI AG in Biosensors
- Vol. 12 (9) , 673
Recent Advances in Digital Biosensing Technology
Digital biosensing assays demonstrate remarkable advantages over conventional biosensing systems because of their ability to achieve single-molecule detection and absolute quantification. Unlike traditional low-abundance biomarking screening, digital-based biosensing systems reduce sample volumes significantly to the fL-nL level, which vastly reduces overall reagent consumption, improves reaction time and throughput, and enables high sensitivity and single target detection. This review presents the current technology for compartmentalizing reactions and their applications in detecting proteins and nucleic acids. We also analyze existing challenges and future opportunities associated with digital biosensing and research opportunities for developing integrated digital biosensing systems.
- 23 August 2022
- Published by MDPI AG in Biosensors
- Vol. 12 (9) , 673
Open AccessRecent Advances in Digital Biosensing Technology
Digital biosensing assays demonstrate remarkable advantages over conventional biosensing systems because of their ability to achieve single-molecule detection and absolute quantification. Unlike traditional low-abundance biomarking screening, digital-based biosensing systems reduce sample volumes significantly to the fL-nL level, which vastly reduces overall reagent consumption, improves reaction time and throughput, and enables high sensitivity and single target detection. This review presents the current technology for compartmentalizing reactions and their applications in detecting proteins and nucleic acids. We also analyze existing challenges and future opportunities associated with digital biosensing and research opportunities for developing integrated digital biosensing systems.